2025-523678-17-00招募中1 期
Phase 1b study to assess the safety and tolerability of SR-878 in patients with rheumatoid arthritis
SciRhom GmbH2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2026年2月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Dr. Jürgen Reeß
Scientific
SciRhom GmbH
研究点 (2)
Loading locations...
相似试验
招募中
2 期
Phase 1b Study to Assess the Safety, Tolerability and Pharmacodynamics of PBFT02 in Adult Participants with Frontotemporal Dementia (FTD) and GRN or C9orf72 Mutations2023-507724-23-00Passage Bio Inc.4
招募中
不适用
A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours)Germ Cell Tumour, Endometrial Cancer and Ovarian CancerjRCT2031260005187
招募中
1 期
A Phase 1b study to evaluate the safety, pharmacokinetics, and anti-tumour activity of the Myc inhibitor OMO-103 administered intravenously in combination with different drugs in patients with advanced solid tumours2023-504376-21-00Peptomyc S.L.30
已完成
1 期
A phase Ib study to investigate the safety and effect of BR-0032024-516338-37-00SentryX B.V.6
招募中
1 期
Phase IB Study to Assess the Safety, Tolerability and Efficacy of PM14 in combination with Atezolizumab in Pretreated Patients with Selected Advanced Solid Tumors2023-509688-25-00Pharma Mar S.A.50